IBI311

Innovent's Tepezza rival one step closer to Chinese approval after phase 3 eye disease win
Fierce Biotech
Tue, 02/20/24 - 05:51 pm
Innovent Biologics
thyroid eye disease
Tepezza
China
Amgen
IBI311